UCL begins first UK deep brain stimulation study for children with rare epilepsy
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
Read More
Tag: epilepsy
NHS to roll out fibre optic laser therapy to prevent seizures in epileptic patients
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
Read More
Brain waves found in sleep shown to protect against epileptic activity
The neurological condition affects around 50 million people worldwide
Read More
NHS to offer epilepsy patients brain laser therapy
The launch of the laser is part of the NHS’s Long Term Plan commitment
Read More
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 people
Read More
Ontozry scores MHRA authorisation for focal-onset seizures
Drug approved to treat adult patients with epilepsy which has not been adequately controlled with at least two anti-epileptic therapies
Read More
EC approval for Ontozry
The drug offers new hope for epilepsy patients with focal-onset seizures
Read More
NHS fast-tracks access to Epidyolex for severe epilepsy
Doctors will be able to prescribe the drug from January 6
Read More
GW Pharma’s Epidiolex nears US launch
GW Pharmaceuticals and its subsidiary Greenwich Biosciences are gearing up to launch Epidiolex in the US after drug enforcement officials re-classified the cannabis-based medicine to the lowest restriction.
Read More
UK announces review of medicinal cannabis
Home secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy.
Read More
MHRA bans valproate without pregnancy prevention programme
The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines, so that they can no longer be prescribed to females of child-bearing age unless they are on the pregnancy prevention programme.
Read More
FDA advisors back approval of GW’s Epidiolex
As expected, an FDA advisory panel has backed approval of GW Pharmaceuticals/Greenwich Bioscience’s Epidiolex for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
